Comparing Know Labs (KNWN) & The Competition

Know Labs (OTCMKTS:KNWNGet Rating) is one of 28 publicly-traded companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it contrast to its peers? We will compare Know Labs to similar businesses based on the strength of its valuation, dividends, risk, earnings, analyst recommendations, institutional ownership and profitability.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Know Labs and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Know Labs 0 0 1 0 3.00
Know Labs Competitors 154 692 956 28 2.47

Know Labs presently has a consensus target price of $7.00, indicating a potential upside of 372.97%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 26.57%. Given Know Labs’ stronger consensus rating and higher possible upside, research analysts clearly believe Know Labs is more favorable than its peers.

Profitability

This table compares Know Labs and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Know Labs N/A -968.13% -192.31%
Know Labs Competitors -3,288.70% 4.83% 1.80%

Valuation & Earnings

This table compares Know Labs and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Know Labs $120,000.00 -$25.36 million -1.85
Know Labs Competitors $2.66 billion $435.24 million 11.21

Know Labs’ peers have higher revenue and earnings than Know Labs. Know Labs is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Know Labs has a beta of 3.05, suggesting that its share price is 205% more volatile than the S&P 500. Comparatively, Know Labs’ peers have a beta of 1.03, suggesting that their average share price is 3% more volatile than the S&P 500.

Institutional & Insider Ownership

10.6% of Know Labs shares are held by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by institutional investors. 44.0% of Know Labs shares are held by company insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Know Labs peers beat Know Labs on 7 of the 13 factors compared.

About Know Labs (Get Rating)

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Want More Great Investing Ideas?

Receive News & Ratings for Know Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Know Labs and related companies with MarketBeat.com's FREE daily email newsletter.